Impact of varicella vaccination in Argentina: Seroprevalence in children and adults in a pediatric hospital
Background: Varicella is the primary infection caused by varicella-zoster virus (VZV). In Argentina, the varicella vaccine was introduced in the National Immunization Programme in 2015 as a single dose scheduled at 15 months of age. Objectives: To estimate VZV seroprevalence in a healthy hospital ba...
Main Authors: | Angela Gentile, María del Valle Juarez, María Florencia Lucion, María Natalia Pejito, Ana Clara Martínez, Agostina Folino, Mariana Viegas, Norberto Giglio |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-04-01
|
Series: | Vaccine: X |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S259013622100053X |
Similar Items
-
Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany
by: Miriam Wiese-Posselt, et al.
Published: (2017-05-01) -
Seroprevalence of varicella antibodies in adults without clinical history of disease
by: Konrad Silva Büchele, et al.
Published: (2020-01-01) -
Seroprevalence rates in children aged 3-6 years after implementing a two-dose varicella vaccination: A observational study
by: Zhuoyu Zhang, et al.
Published: (2023-01-01) -
Varicella prevention – a lifelong and challenging affair
by: Ulrich Heininger
Published: (2016-09-01) -
Seroprevalence and molecular characteristics of varicella-zoster virus infection in Chinese children
by: Lin Luan, et al.
Published: (2019-07-01)